Power 90 Clinical Trials
- The "Power 15 Study": Safety Study of Inhalation of Ventavis With the Power Disc 15 Setting
ClinicalTrials.gov Identifier: NCT00467896 - Recruiting
Pulmonary Hypertension
- Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer
ClinicalTrials.gov Identifier: NCT00006368 - Active, not recruiting
Lung Cancer; Melanoma; Lymphoma; Brain Tumor; Breast Cancer
- A Multicenter, Randomized, Double-Blind, Comparative Study to Evaluate the Safety, Tolerability, and Efficacy of 2 Dosing Regimens of an Antifungal Drug in the Treatment of Fungal Infections in Adults
ClinicalTrials.gov Identifier: NCT00250432 - Recruiting
Invasive Candidiasis
- Brain Power: Resistance Training and Cognitive Function
ClinicalTrials.gov Identifier: NCT00426881 - Active, not recruiting
Healthy
- Yttrium Y 90 Ibritumomab Tiuxetan, Etoposide, Cyclophosphamide, and an Autologous Stem Cell Transplant in Treating Patients With Non-Hodgkin Lymphoma
ClinicalTrials.gov Identifier: NCT00562978 - Active, not recruiting
Lymphoma
- CpG 7909, Rituximab, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Non-Hodgkin's Lymphoma That is Recurrent or Did Not Respond to Previous Treatment
ClinicalTrials.gov Identifier: NCT00438880 - Active, not recruiting
Lymphoma
- PBWST (Partial Body-Weight Supported Treadmill Training) and Muscle Power Training after Sub-acute Stroke
ClinicalTrials.gov Identifier: NCT00108030 - Recruiting
Stroke
- Effect of Pterygium Excision on Intraocular Lens Power Calculation for Subsequent Cataract Operation
ClinicalTrials.gov Identifier: NCT00563667 - Active, not recruiting
Pterygium; Cataract; Astigmatism
- Treatment With [90]Y-Ibritumomab Tiuxetan Versus no Treatment in Patients With Follicular Non Hodgkin Lymphoma (Stage III or IV) Having Achieved a Partial or Complete Remission After First Line Chemotherapy
ClinicalTrials.gov Identifier: NCT00185393 - Active, not recruiting
Non Hodgkin Lymphoma
- Rituximab, Prednisone, Cyclophosphamide, Doxorubicin, Vincristine, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Previously Untreated Mantle Cell Lymphoma
ClinicalTrials.gov Identifier: NCT00070447 - Active, not recruiting
contiguous stage II mantle cell lymphoma; noncontiguous stage II mantle cell lymphoma; stage III mantle cell lymphoma; stage IV mantle cell lymphoma
- Dose-Effect of S-Tenatoprazole-Na(STU-Na) 30 mg, 60 mg, 90 mg and 120 mg in Healthy Volunteers
ClinicalTrials.gov Identifier: NCT00284908 - Active, not recruiting
Esophagitis; Gastroesophageal Reflux; Stomach Ulcer; Duodenal Ulcer
- Yttrium Y 90 Ibritumomab Tiuxetan, Fludarabine, and Radiation Therapy in Treating Patients Who Are Undergoing a Donor Stem Cell Transplant for Relapsed Or Refractory Non-Hodgkin''s Lymphoma
ClinicalTrials.gov Identifier: NCT00119392 - Recruiting
adult non-Hodgkin''s lymphoma
- Phase I/II Study of Tac-Expressing Malignancies [Other than Adult T-Cell Leukemia (ATL)] with Yttrium-90 Radiolabeled Humanized Anti-Tac and Calcium-DTPA
ClinicalTrials.gov Identifier: NCT00001575 - Recruiting
Cutaneous T Cell Lymphoma; Hodgkin's Disease; Neoplasm; Non Hodgkin's Lymphoma; Peripheral T Cell Lymphoma
- Impact of Pushrim Activated Power Assist Wheelchairs on Mobility Among People With Tetraplegia
ClinicalTrials.gov Identifier: NCT00281463 - Recruiting
Wheelchair Users
- Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00110149 - Recruiting
grade 1 follicular lymphoma; grade 2 follicular lymphoma; marginal zone lymphoma; Small Lymphocytic Lymphoma
- Comparative Study of Three IOL Power Calculation Formulae for Asian Eyes Shorter Than 22mm or Longer Than 25mm
ClinicalTrials.gov Identifier: NCT00347516 - Recruiting
Cataract
- Iodine I 131 Tositumomab or Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00416312 - Recruiting
Lymphoma
- Yttrium Y 90 Ibritumomab Tiuxetan and Rituximab in Treating Patients With Previously Untreated Marginal Zone Lymphoma
ClinicalTrials.gov Identifier: NCT00453102 - Recruiting
Lymphoma
- Use of TheraSphere® Yttrium-90 Glass Microspheres for Primary and Metastatic Liver Tumors
ClinicalTrials.gov Identifier: NCT00493883 - Recruiting
Carcinoma, Hepatocellular; Liver Neoplasms
- Motexafin Gadolinium, Rituximab, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Stage II, Stage III, or Stage IV Relapsed or Refractory Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00089284 - Recruiting
adult non-Hodgkin's lymphoma; indolent or aggressive adult non-Hodgkin's lymphoma
- Bortezomib, Rituximab, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed or Refractory Follicular Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00372905 - Recruiting
Lymphoma
- Rituximab, Fludarabine, Cyclophosphamide, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed B-Cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00397800 - Recruiting
Lymphoma
- Rituximab, Combination Chemotherapy, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Stage I or Stage II Lymphoma
ClinicalTrials.gov Identifier: NCT00088881 - Recruiting
stage I adult diffuse large cell lymphoma; stage II adult diffuse large cell lymphoma
- Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Lymphoma or Leukemia
ClinicalTrials.gov Identifier: NCT00004084 - Active, not recruiting
Leukemia; Lymphoma
- Bortezomib, Rituximab, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed or Refractory Low-Grade, Follicular, or Mantle Cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00334438 - Recruiting
Lymphoma
- Yttrium Y 90 Ibritumomab Tiuxetan and Rituximab in Treating Patients With Relapsed or Refractory Diffuse Large B-Cell Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00073957 - Recruiting
recurrent adult diffuse large cell lymphoma; recurrent adult immunoblastic large cell lymphoma; anaplastic large cell lymphoma
- Melphalan, Yttrium Y 90 Ibritumomab Tiuxetan, and Rituximab Followed by Autologous Stem Cell Transplant in Treating Older Patients With Non-Hodgkin's Lymphoma That Has Relapsed or Not Responded to Previous Treatment
ClinicalTrials.gov Identifier: NCT00392691 - Recruiting
Lymphoma
- AFR10 - Combination Therapy of Imatinib Mesylate (IM) + Alpha-2A Interferon for Chronic Phase CML Patients Resistant or Refractory to IM Used as Single Therapy for at Least One Year
ClinicalTrials.gov Identifier: NCT00146913 - Active, not recruiting
Chronic Myeloid Leukemia
- Radioimmunotherapy With or Without Chemotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Thyroid Cancer
ClinicalTrials.gov Identifier: NCT00004048 - Active, not recruiting
medullary thyroid cancer
- Comparing Hepatic Intra-Arterial Injection of Yttrium-90 Microspheres Versus Fluorouracil (5FU) in Colorectal Cancer Metastatic to the Liver Only
ClinicalTrials.gov Identifier: NCT00199173 - Recruiting
Colorectal Neoplasm; Liver Metastases
- Treatment of Myeloma in Patients <= 65 Years Old With Response >= 50% and <= 90% After HSC Autotransplant by Allogenic Transplant Genoidentical or Phenoidentical After Reduced Intensity Conditioning
ClinicalTrials.gov Identifier: NCT00466674 - Recruiting
Myeloma
- Yttrium Y 90 Ibritumomab Tiuxetan, Rituximab, Fludarabine, Melphalan, and Donor Stem Cell Transplant in Treating Patients With B-Cell Non-Hodgkin Lymphoma
ClinicalTrials.gov Identifier: NCT00577278 - Recruiting
Graft Versus Host Disease; Leukemia; Lymphoma
- Studying Thyroid Cancer and Other Thyroid Diseases in Participants Who Were Children in Ukraine During the Chernobyl Nuclear Power Plant Accident
ClinicalTrials.gov Identifier: NCT00558610 - Recruiting
Head and Neck Cancer
- Yttrium Y 90 DOTA Monoclonal Antibody HuPAM4 in Treating Patients With Stage III or Stage IV Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00303680 - Recruiting
Pancreatic Cancer
- Rituximab and Combination Chemotherapy Combined With Yttrium Y 90 Ibritumomab Tiuxetan in Treating Older Patients With Previously Untreated B-Cell Lymphoma
ClinicalTrials.gov Identifier: NCT00058422 - Recruiting
noncontiguous stage II adult diffuse large cell lymphoma; stage III adult diffuse large cell lymphoma; stage IV adult diffuse large cell lymphoma
- Rituximab, Yttrium Y 90 Ibritumomab Tiuxetan, Melphalan, and Autologous Peripheral Stem Cell Transplant in Treating Patients With Previously Treated Multiple Myeloma
ClinicalTrials.gov Identifier: NCT00477815 - Recruiting
Multiple Myeloma and Plasma Cell Neoplasm
- Cyclophosphamide, Doxorubicin, Vincristine, Prednisone, and Radiation Therapy Followed By Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Stage I or Stage II Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00070018 - Recruiting
adult Burkitt's lymphoma; adult diffuse large cell lymphoma; adult non-Hodgkin's lymphoma; anaplastic large cell lymphoma; Mantle Cell Lymphoma
- Radiolabeled Monoclonal Antibody Plus Peripheral Stem Cell Transplantation in Treating Patients With Refractory or Recurrent Ovarian Epithelial Cancer
ClinicalTrials.gov Identifier: NCT00004177 - Active, not recruiting
recurrent ovarian epithelial cancer
- Monoclonal Antibody Therapy Plus Cyclosporine and Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00003920 - Active, not recruiting
stage IV breast cancer; recurrent breast cancer
- Radioimmunotherapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Stage IV Breast Cancer
ClinicalTrials.gov Identifier: NCT00004085 - Active, not recruiting
stage IV breast cancer; recurrent breast cancer
- Treatment of Patients With Advanced Renal Cancer With a Radio-Labeled Antibody, Yttrium-90 Conjugated Chimeric G250.
ClinicalTrials.gov Identifier: NCT00199875 - Recruiting
Renal Cell Carcinoma; Kidney Neoplasm; Renal Cancer; Kidney Cancer
- Monoclonal Antibody Therapy, Paclitaxel, and Cyclosporine in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00009776 - Active, not recruiting
Burkitt's Lymphoma; Lymphocytic Lymphoma
- Internal Radiation Therapy With Y-90 Microspheres, External Radiation Therapy With Tomotherapy, and Fluorouracil in Treating Patients With Newly Diagnosed or Recurrent Pancreatic Cancer and Liver Metastases That Cannot Be Removed By Surgery
ClinicalTrials.gov Identifier: NCT00436267 - Recruiting
Metastatic Cancer; Pancreatic Cancer
- Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00006347 - Active, not recruiting
Recurrent Small Cell Lung Cancer
- Radiolabeled Monoclonal Antibody, Paclitaxel, and Interferon alfa in Treating Patients With Recurrent Ovarian Cancer
ClinicalTrials.gov Identifier: NCT00002734 - Active, not recruiting
recurrent ovarian epithelial cancer; peritoneal cavity cancer
- Radiolabeled Monoclonal Antibody in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00033423 - Active, not recruiting
grade 1 follicular lymphoma; grade 2 follicular lymphoma; grade 3 follicular lymphoma; marginal zone lymphoma; Small Lymphocytic Lymphoma
- Radiolabeled Monoclonal Antibody Therapy and High-Dose Chemotherapy Followed By Autologous Peripheral Stem Cell Transplantation in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00058292 - Active, not recruiting
adult non-Hodgkin's lymphoma
- FRALYSE Trial
ClinicalTrials.gov Identifier: NCT00132509 - Recruiting
Acute ischemic stroke
- Monoclonal Antibody Therapy, Cyclosporine, and Paclitaxel in Treating Patients With Recurrent or Refractory Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00009763 - Active, not recruiting
stage IV breast cancer; recurrent breast cancer
- Radiolabeled SMT-487 in Treating Patients With Refractory Small Cell Lung Cancer or Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00006370 - Active, not recruiting
Male Breast Cancer; Recurrent Small Cell Lung Cancer; stage IV breast cancer; recurrent breast cancer
- Hepatic Arterial Chemoembolization With Cisplatin or Internal Radiation Therapy in Treating Patients With Advanced Liver Cancer That Cannot Be Removed By Surgery
ClinicalTrials.gov Identifier: NCT00109954 - Active, not recruiting
adult primary hepatocellular carcinoma; advanced adult primary liver cancer; localized unresectable adult primary liver cancer; ...
- Monoclonal Antibody Therapy, Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Refractory Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00008021 - Active, not recruiting
Burkitt's Lymphoma; Lymphoblastic Lymphoma; Myeloid Leukemia
- Monoclonal Antibody Therapy Plus Chemotherapy Followed by Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Prostate Cancer That Has Not Responded to Hormone Therapy
ClinicalTrials.gov Identifier: NCT00009750 - Active, not recruiting
stage IV prostate cancer; recurrent prostate cancer
- Radiolabeled Monoclonal Antibody Therapy in Treating Patients With Relapsed or Refractory Non-small Cell Lung Cancer
ClinicalTrials.gov Identifier: NCT00006458 - Active, not recruiting
Adenosquamous Cell Lung Cancer; Squamous Cell Lung Cancer; recurrent non-small cell lung cancer; Adenocarcinoma of the Lung; large cell lung cancer
- Radiolabeled Monoclonal Antibody Therapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Metastatic or Recurrent Colorectal Cancer or Pancreatic Cancer
ClinicalTrials.gov Identifier: NCT00004087 - Active, not recruiting
recurrent colon cancer; recurrent pancreatic cancer; stage IV pancreatic cancer; Stage IV rectal cancer; recurrent rectal cancer; ...
- Monoclonal Antibody Therapy in Treating Patients With Ovarian Cancer or Primary Peritoneal Cancer in Remission Following Surgery and Chemotherapy
ClinicalTrials.gov Identifier: NCT00004115 - Active, not recruiting
stage I ovarian epithelial cancer; stage II ovarian epithelial cancer; stage III ovarian epithelial cancer; stage IV ovarian epithelial cancer; ...
- Hypertension Related Damage to the Microcirculation in South Asian: Emergence, Predictive Power and Reversibility
ClinicalTrials.gov Identifier: NCT00331370 - Not yet recruiting
Hypertension; Diabetes; Cardiovascular Disease; Retinopathy
- NNC 90-1170 Mechanism of Action: A double-blind, randomized, single-center, placebo-controlled, crossover study to examine beta-cell responsiveness to graded glucose infusion in subjects with type 2 diabetes
ClinicalTrials.gov Identifier: NCT00013910 - Completed
Diabetes Mellitus, Non-Insulin-Dependent
- Power Wheelchair Joystick Use in Spastic Cerebral Palsy
ClinicalTrials.gov Identifier: NCT00337688 - Not yet recruiting
Cerebral Palsy; Spasticity
- Radiolabeled Monoclonal Antibody, Combination Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent or Refractory B-Cell Cancer
ClinicalTrials.gov Identifier: NCT00004086 - Active, not recruiting
recurrent diffuse small lymphocytic/marginal zone lymphoma; recurrent adult diffuse small cleaved cell lymphoma; ...
- Radiolabeled Monoclonal Antibody Therapy Plus Peripheral Stem Cell Transplantation in Treating Patients With Lymphoma or Waldenstrom's Macroglobulinemia
ClinicalTrials.gov Identifier: NCT00004107 - Active, not recruiting
recurrent diffuse small lymphocytic/marginal zone lymphoma; recurrent adult diffuse small cleaved cell lymphoma; ...
- Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Waldenstrom's Macroglobulinemia
ClinicalTrials.gov Identifier: NCT00060294 - Completed
Waldenstrom's Macroglobulinemia
- Hepatic Arterial Infusion Plus Internal Radiation Therapy in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery
ClinicalTrials.gov Identifier: NCT00039078 - Recruiting
localized unresectable adult primary liver cancer; recurrent adult primary liver cancer; adult primary hepatocellular carcinoma
- Radiolabeled Octreotide in Treating Children With Advanced or Refractory Solid Tumors
ClinicalTrials.gov Identifier: NCT00049023 - Recruiting
Ewing's family of tumors; adult solid tumor; childhood brain tumor; childhood solid tumor; Gastrointestinal Cancer; Neuroblastoma
- Monoclonal Antibody Therapy and Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00017381 - Recruiting
adult non-Hodgkin's lymphoma; indolent or aggressive adult non-Hodgkin's lymphoma
- Phase I/II Study of Tac-Expressing Adult T-Cell Leukemia (ATL) with Yttrium-90 (90Y)-Radiolabeled Humanized Anti-Tac Monoclonal Antibody and Calcium-DTPA
ClinicalTrials.gov Identifier: NCT00001514 - Completed
T Cell Leukemia
- Radiolabeled Monoclonal Antibody Plus Rituximab With and Without Filgrastim and Interleukin-11 in Treating Patients With Relapsed or Refractory Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00012298 - Recruiting
grade 1 follicular lymphoma; grade 2 follicular lymphoma; grade 3 follicular lymphoma; indolent, adult non-Hodgkin's lymphoma; marginal zone lymphoma; ...
- Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Recurrent Primary CNS Lymphoma
ClinicalTrials.gov Identifier: NCT00082836 - Completed
primary central nervous system lymphoma
- Testing the POWER Project: A Neighborhood Intervention Trial
ClinicalTrials.gov Identifier: NCT00164671 - Completed
Condom Use
- Efficacy and Safety of Lanreotide Autogel (60, 90 or 120 Mg) in Acromegalic Patients
ClinicalTrials.gov Identifier: NCT00210457 - Completed
Acromegaly
- POWER Point of Care Effect on Satisfaction of Treatment
ClinicalTrials.gov Identifier: NCT00549068 - Completed
Osteoporosis, Postmenopausal
- POWER (Pulse Width Optimized Waveform Evaluation Trial)
ClinicalTrials.gov Identifier: NCT00311181 - Completed
Sudden Cardiac Death
- A 28 - 90 Days Study to Evaluate the Safety, Tolerability, and Efficacy of Caspofungin Injection as Empirical Therapy in Indian Adults With Persistent Fever and Neutropenia
ClinicalTrials.gov Identifier: NCT00379964 - Completed
Fungal Infection
- Yttrium Y 90 Ibritumomab Tiuxetan and Rituximab in Treating Patients With Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00062114 - Completed
recurrent adult diffuse large cell lymphoma; recurrent adult diffuse mixed cell lymphoma; recurrent adult immunoblastic large cell lymphoma
- Study Comparing Two Manufacturing Processes for Levonorgestrel 90 mg/Ethinyl Estradiol 20 mg (LNG/EE) in Healthy, Cycling Women
ClinicalTrials.gov Identifier: NCT00319163 - Completed
Healthy
- Yttrium Y 90 Ibritumomab Tiuxetan and Rituximab in Treating Patients With Post-Transplant Lymphoproliferative Disorder
ClinicalTrials.gov Identifier: NCT00064246 - Completed
adult Burkitt's lymphoma; adult diffuse large cell lymphoma; indolent, adult non-Hodgkin's lymphoma; post-transplant lymphoproliferative disorder
- A Study to Evaluate 90-Day Safety of Tapentadol(CG5503) Immediate Release (IR) or Oxycodone Immediate Release in Patients With Chronic Pain
ClinicalTrials.gov Identifier: NCT00364546 - Completed
Low Back Pain; Pain Intensity Assessment; Osteoarthritis; Arthralgia; Sciatica
- Dose Density FU 75 and FU 90 as Adjuvant Therapy for Early Breast Cancer
ClinicalTrials.gov Identifier: NCT00286819 - Completed
Breast Cancer
- Accuracy of the Pentacam and IOL Master to Calculate the Effective Corneal Power After Corneal Refractive Surgery
ClinicalTrials.gov Identifier: NCT00466908 - Completed
Cataract Extraction; Refractive Surgery
- Open-Label, Dose-Escalation Study of 2 to 5 IM Doses of MEDI-524 at 3 mg/kg or 15 mg/kg; Children to be Followed for 90 Days After Their Last Dose of MEDI-524
ClinicalTrials.gov Identifier: NCT00192478 - Completed
Respiratory Syncytial Virus Infections
- Pamidronate Prophylaxis in Multiple Myeloma 30 mg/Month Versus 90 mg/Month
ClinicalTrials.gov Identifier: NCT00376883 - Completed
Multiple Myeloma
- Yttrium-90 Ibritumomab Tiuxetan (Zevalin) with BEAM in Relapsed Low Grade B-Cell Lymphoma
ClinicalTrials.gov Identifier: NCT00138086 - Completed
B Cell Lymphoma
- Randomized, Phase I/II, Dose-Ranging, Open-Label Trial of the Anti-HIV Activity of Delavirdine Mesylate (DLV; U-90,152S)
ClinicalTrials.gov Identifier: NCT00000810 - Completed
HIV Infections
- Treatment of Tac-Expressing Cutaneous T-Cell Lymphoma (CTCL) and Adult T-Cell Leukemia (ATL) with Yttrium-90 Radiolabeled Anti-Tac
ClinicalTrials.gov Identifier: NCT00001249 - Completed
Leukemia, T-Cell; Lymphoma, T-Cell, Cutaneous
- Monoclonal Antibody Therapy in Treating Patients With Non-Hodgkin's Lymphoma That Has Relapsed After High-Dose Chemotherapy and Autologous Stem Cell Transplantation
ClinicalTrials.gov Identifier: NCT00031642 - Completed
adult non-Hodgkin's lymphoma
- Radiolabeled Monoclonal Antibody in Treating Patients With Advanced Ovarian Epithelial Cancer
ClinicalTrials.gov Identifier: NCT00072410 - Completed
recurrent ovarian epithelial cancer; stage III ovarian epithelial cancer
- Radiolabeled Monoclonal Antibody Therapy Followed by Bone Marrow or Peripheral Stem Cell Transplantation in Treating Patients With Metastatic Breast Cancer
ClinicalTrials.gov Identifier: NCT00007891 - Completed
stage IV breast cancer; recurrent breast cancer
- Radiolabeled Monoclonal Antibody With or Without Peripheral Stem Cell Transplantation in Treating Children With Recurrent or Refractory Lymphoma
ClinicalTrials.gov Identifier: NCT00036855 - Completed
AIDS-Related Lymphoma; childhood large cell lymphoma; childhood lymphoblastic lymphoma; childhood small noncleaved cell lymphoma; ...
- Radiolabeled Monoclonal Antibody Therapy and Etoposide Followed by Peripheral Stem Cell Transplantation in Treating Patients With Advanced Myelodysplastic Syndrome or Refractory Leukemia
ClinicalTrials.gov Identifier: NCT00006040 - Completed
adult acute lymphoblastic leukemia; adult acute myeloid leukemia; atypical chronic myeloid leukemia; ...
[ Disclaimer: The information on GoldBamboo for any particular treatment, medicine, drug, or herbal product might be missing or incomplete, and should never be used as a single source of knowledge. GoldBamboo generally has links to authoritative sites displayed toward the bottom of each topic page under the heading "Resources". ]
| 
Not Signed In - 
email this page
print this page
bookmark this page
feedback on this page
